kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the GSK dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for GSK.

GSK

GSK plc
Pharmaceuticals · Pharmaceuticals
$174.03 sample
-1.26 (-0.72%) 1D
☆ Watch
Market cap
$181.6B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-15
Alerts
8
Price$174.03 -3.36% 3M daily closessample
185.72171.84
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 26INSInsider buy: Chief Financial Officer
  • Oct 15SECDEF 14A filed
  • Oct 08INSInsider sell: Director
  • Sep 29INSInsider buy: Chief Executive Officer
  • Sep 21INSInsider buy: Director
  • Sep 14INSInsider sell: General Counsel
  • Sep 08SECDEF 14A filed
  • Sep 03SECDEF 14A filed
Sign up to see the real GSK record →

Company facts

SEC EDGAR registration
Name
GSK plc
Sector
Pharmaceuticals
Industry
Pharmaceuticals
Smart-money score
-45sample, -100 to +100
Reporting currency
USD

Who is positioning in GSK

sample
Insiders
18 insider transactions over 90 days, net selling, $570.0M
Congress
4 members traded over 90 days
Institutions · 13F
41 funds hold $2.3B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$12.3B +18.3% y/y
Q4 2024Q3 2026
Inventory$7.0B +6.5% y/y
Q4 2024Q3 2026
Accounts receivable$5.2B +2.4% y/y
Q4 2024Q3 2026
Total debt$14.8B +15.0% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$54.3B +16.3% 3M
Sample peer B
$174.9B -11.2% 3M
Sample peer C
$162.7B +7.3% 3M
Sample peer D
$105.9B -12.9% 3M
Sample peer E
$153.8B +11.1% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not GSK's real figure. Nothing here is investment advice.